Finance

Lists
BRVE:NASDAQ
Braveheart Bio Inc
$26.64
-2.24%
(-0.61) 1D
$26.64
0.00% (0.00)
After hours
Closed: Sep 11, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BRVE...
Open
$28.12
High
$28.74
Low
$26.54
Mkt. cap
2.40B
Avg. vol.
400.34K
Volume
283.59K
52-wk high
$32.00
52-wk low
$24.30
EPS
-$1.29
No. of employees
30
Open
$28.12
High
$28.74
Low
$26.54
Mkt. cap
2.40B
Avg. vol.
400.34K
Volume
283.59K
52-wk high
$32.00
52-wk low
$24.30
EPS
-$1.29
No. of employees
30
News stories
From web sources and news partners
About Braveheart Bio Inc
CEO-
Employees30
Founded2024
HeadquartersSan Francisco, California, United States
SectorBiotechnology
Websitebraveheart.bio
Analyst ratings
Based on 5 analysts giving stock ratings to BRVE in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for BRVE in the last 3 months.
Highest
Current $26.64
$48.00 (+80.18%)
Average
$45.25 (+69.86%)
Lowest
$40.00 (+50.15%)
Analyst
Recommendation
Action
Price target
Projected
Date
Salveen Richter
Goldman Sachs
Buy
Maintained
$48.00
+80.2%
09/08/2026
James Condulis
Stifel Nicolaus
Buy
Reiterated
$45.00
+68.9%
09/09/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Initiated
$40.00
+50.2%
08/31/2026
Tyler Van Buren
TD Cowen
Buy
Initiated
-
-
08/31/2026
Nimrod Tevet
Jefferies
Buy
Initiated
$48.00
+80.2%
08/31/2026
Andrew Tsai
Jefferies
Buy
Initiated
$48.00
+80.2%
08/31/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
94.00K
10.91M
Total research and development expenses
-
-
Selling, general, and admin expenses
5.00K
4.14M
Operating expense
99.00K
15.05M
Total operating expenses
99.00K
15.05M
Operating income
-99.00K
-15.05M
Other non operating income
-
-2.00K
EBT including unusual items
-99.00K
-14.28M
EBT excluding unusual items
-99.00K
-14.28M
Income tax expense
-
-
Effective tax rate
-
-
Other operating expenses
-
-
Net income
-99.00K
-14.28M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
-
771.00K
Interest expense
-
-
Net interest expenses
-
771.00K
Depreciation and amortization charges
-
-
EBITDA
-
-15.05M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps